These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6150627)

  • 61. [Hypertension treatment in the practice. Study with the beta receptor blocker bupranolol].
    Schrey A
    Med Welt; 1981 Jan; 32(2):58-62. PubMed ID: 6259489
    [No Abstract]   [Full Text] [Related]  

  • 62. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atenolol pretreatment in fiberoptic bronchoscopy. Effect on cardiac arrhythmias, heart rate and arterial blood pressure.
    Fassoulaki A; Kaniaris P; Kotsanis S
    Acta Anaesthesiol Belg; 1980; 31(4):279-84. PubMed ID: 7223351
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target?
    Herman M; Donovan J; Tran M; McKenna B; Gore JM; Goldberg RJ; Tighe DA
    Am Heart J; 2009 Sep; 158(3):378-85. PubMed ID: 19699860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448
    [No Abstract]   [Full Text] [Related]  

  • 66. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.
    Hjalmarson A; Herlitz J; Holmberg S; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Circulation; 1983 Jun; 67(6 Pt 2):I26-32. PubMed ID: 6342837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
    Daga MK; Chaudhary M; Sharma B; Bhattacharjee J; Ghambhir DS; Arora N; Sudha R
    J Assoc Physicians India; 2003 Jul; 51():677-80. PubMed ID: 14621036
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical evaluation of alpha-acetyldigoxin].
    Woie L; Aksnes EG
    Nord Med; 1971 Apr; 85(13):404-8. PubMed ID: 4928927
    [No Abstract]   [Full Text] [Related]  

  • 71. [The immediate effect of trimepranol on central and peripheral hemodynamics in arterial hypertension].
    Kaderavek F; Polák J; Sikýrová E
    Fysiatr Revmatol Vestn; 1980 Jun; 58(3):130-6. PubMed ID: 6104625
    [No Abstract]   [Full Text] [Related]  

  • 72. [Interaction of trimepranol and uric acid].
    Sulková A; Kolláriková E; L' Krasnec
    Cesk Farm; 1980 Nov; 29(8-9):294-5. PubMed ID: 6109572
    [No Abstract]   [Full Text] [Related]  

  • 73. Spontaneous motor activity in rats given repeatedly beta-sympatholytics, propranolol and trimepranol.
    Tikal K; Hvizdosová J; Pavlovicová E
    Act Nerv Super (Praha); 1980 Mar; 22(1):71-2. PubMed ID: 6104410
    [No Abstract]   [Full Text] [Related]  

  • 74. Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker.
    Derous D; de Keizer RJ; de Wolff-Rouendaal D; Soudijn W
    Acta Ophthalmol (Copenh); 1989 Jun; 67(3):333-8. PubMed ID: 2475010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The toxic effects and pharmacokinetics of lanatoside C in animals with experimental radiation sickness or trimepranol premedication].
    Tilser I; Chmelar V; Krupicková H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(4):497-511. PubMed ID: 6111840
    [No Abstract]   [Full Text] [Related]  

  • 76. [Determination of trimepranol, chlorthalidone, DH-ergocristine and amiloride simultaneously].
    Peterková M; Kakác B; Matousová O
    Cesk Farm; 1980 Sep; 29(7):241-3. PubMed ID: 6110484
    [No Abstract]   [Full Text] [Related]  

  • 77. Trimepranol, a Czechoslovak-made beta blocker, in the treatment of acute myocardial infarction.
    Charvát J; Pavlovic J; Fiserová J
    Acta Univ Carol Med (Praha); 1984; 30(1-2):117-23. PubMed ID: 6150627
    [No Abstract]   [Full Text] [Related]  

  • 78. [Hemodynamic effects and tolerance for trimepranol in acute myocardial infarct].
    Pavlovic J; Charvát J; Fiserová J
    Vnitr Lek; 1982 Dec; 28(12):1191-7. PubMed ID: 6130651
    [No Abstract]   [Full Text] [Related]  

  • 79. [The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination].
    Teufel W; Glocke M
    Med Klin; 1981 Aug; 76(18):513-5. PubMed ID: 6116170
    [No Abstract]   [Full Text] [Related]  

  • 80. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.